Tali-Anne Szwebel to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications Tali-Anne Szwebel has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.030
-
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. Eur J Cancer. 2017 09; 82:34-44.
Score: 0.030